Skip to main content
The Journal of Clinical Hypertension logoLink to The Journal of Clinical Hypertension
. 2020 Aug 11;22(10):1797–1799. doi: 10.1111/jch.13969

Pulsatile and steady‐state 24‐hour hemodynamics in adolescents and young adults: The next steps ahead

Thomas Weber 1,, Athanasios D Protogerou 2, James E Sharman 3, Siegfried Wassertheurer 4
PMCID: PMC8029684  PMID: 32780935

Starting with the recording of pulse waves almost 150 years ago, non‐invasive measurement of blood pressure (BP) at the upper arm in the doctor's office more than 100 years ago, and ambulatory recordings of brachial BP more than 50 years ago, our understanding of the physiology of the circulation has tremendously improved. Beyond BP, the focus of hemodynamics was on the relationship “mean arterial pressure = cardiac output × peripheral resistance.” These so‐called steady‐state hemodynamics did not take pulsatile phenomena (pulsatile pressure and flow, as determined by the pulsatile nature of the heart) into account, but led to the first successful and lifesaving clinical trials in hypertension 1967—notably targeting diastolic BP, 1 which can be seen as somewhat closer to mean arterial BP. Steady‐state hemodynamics dominated research for decades and convey important insights even in recent studies. 2 Treatment targeted on systolic BP rather than diastolic BP was proven beneficial 20 years later (even in isolated systolic hypertension). 3

The most recent decades have seen a rising interest in pulsatile aspects of the arterial circulation, comprising not only brachial systolic BP and pulse pressure, but extending to central pressures, measures of wave reflections and aortic stiffness. All sophisticated measurements beyond brachial BP, however, could be performed exclusively in the doctor's office. Assessment of 24‐hour hemodynamics was restricted to invasive clinic measurement (focused on steady‐state aspects of the circulation) or to ambulatory 24‐hour monitoring of brachial BP and, not to forget, heart rate. Only in the last few years, technological progress made the development of automated brachial cuff‐based sphygmomanometers for 24‐hour assessment possible, which not only measure brachial BP and heart rate, but also—through recording and analysis of pulse waveforms—purport to measure or estimate pulsatile (central BP, wave reflections, arterial stiffness) and steady‐state (cardiac output, peripheral resistance) hemodynamics. 4 , 5 , 6

Against this background, as reported in the current issue of the Journal, 7 Ntineri and colleagues from Athens, Greece, investigated 24‐hour central ambulatory BP and 24‐hour ambulatory pulsatile and steady‐state hemodynamics in 136 adolescents and young adults (range 10‐25 years), using an automated oscillometric upper‐arm cuff device (Mobil‐O‐Graph 24h PWA, Stolberg, Germany). Twenty‐five percent of participants were healthy volunteers, 34% had elevated 24‐hour brachial BP, but all were free from antihypertensive medications. Central systolic BP was calculated by the device using two different calibration methods (C1SBP using brachial systolic and diastolic BP, and C2SBP using oscillometrically measured mean/diastolic BP). 24‐hour brachial SBP was higher than C1SBP, with the difference (systolic BP amplification) being more pronounced during daytime than nighttime. Other determinants of SBP amplification were age, body height, and sex. Consequently, nighttime dipping of C1SBP was smaller, as compared to brachial SBP. In contrast, C2SBP increased (by 3.1 mm Hg) during nighttime sleep. The main focus of the analysis was on circadian changes of brachial and central systolic BP, taking two options of waveform calibration into account; however, the authors took advantage of the full set of hemodynamic variables provided by the device to describe the circadian variation in all parameters (Table 1).

Table 1.

Circadian variations in key steady‐state and pulsatile hemodynamic variables, according to Ntineri and colleagues

Hemodynamic variable Change from daytime to nighttime (“dipping”)
Brachial systolic BP
Central systolic BP (systolic/diastolic BP calibration—“C1”)
Central systolic BP (mean/diastolic BP calibration—“C2”)
Systolic BP amplification
Diastolic BP
Mean BP
Heart rate
Brachial pulse pressure ⇓ ⇔
Central pulse pressure (systolic/diastolic BP calibration—“C1”)
Central pulse pressure (mean/diastolic BP calibration—“C2”)
Augmentation index
Cardiac output
Stroke volume
Peripheral resistance ⇓ ⇔
Pulse wave velocity

The authors have to be applauded for this endeavor for several reasons. Firstly, they provide new insights into circadian changes of central BPs in adolescents and young adults. These data may serve therefore as the first reported reference and comparator for healthy aging in young people, albeit acknowledging the relatively small sample. Potentially even more important, and going beyond BP, a full set of steady‐state and pulsatile hemodynamics is provided in this young and relatively healthy group of participants. In future studies, the effects of healthy aging and of various diseases which disrupt hemodynamics, such as hypertension, diabetes, heart failure, and renal failure, could be compared with the Ntineri findings.

The results of the study pose important questions: Has the time‐honored sphygmomanometer evolved to a fully automated, non‐invasive, easy‐to‐use, accurate and relatively cheap hemodynamic monitor, capable of 24‐hour ambulatory recordings? Where are we in the process of technical and clinical validation of the devices purporting to measure central BP and hemodynamics 4 , 5 , 6 ? and Is there room for improvement? For the reason of article length, we will focus here on the apparatus used in the study by Ntineri and colleagues. For other methods and devices, particularly those measuring pulsatile hemodynamics, we refer to the ongoing European COoperation in Science and Technology Action VascAgeNet, 8 addressing many of these issues together with the ARTERY Society.

Regarding accuracy, many studies have sought to determine the accuracy of the Mobil‐O‐Graph 24h PWA device for measuring brachial BP, 9 , 10 central BP, 4 , 11 wave reflections, 12 , 13 estimated aortic pulse wave velocity, 14 , 15 and stroke volume 16 , 17 in adults. Taken together, all studies showed at least a reasonable agreement with the reference standard. However, in children, two recent studies showed C1SBP to be overestimated compared with the invasive gold standard (by 2.0 mm Hg 18 and 5.7 mm Hg 19 ). Of note, whereas in adults the C2 calibration is more accurate than C1 calibration, 4 , 20 in children C2 calibration may lead to sizeable overestimation of central systolic BP (mean 19.1 mm Hg). 19 Moreover, a contributory source of error in central systolic BP estimation is inaccuracies of the cuff brachial BP used for waveform calibration. Importantly, the magnitude of cuff brachial BP error is age‐dependent 21 and this is likely to be an influential factor on the central SBP differences observed by Ntineri et al between C1 and C2 calibrations. Our conclusion here is that we need more high‐quality invasive validation studies to determine the accuracy of central BP devices across different age groups, but also more rigor in the validation of conventional oscillometric brachial BP devices used to calibrate central BP devices.

Regarding clinical validation (eg, association of BP values with clinical outcomes), studies so far have focused on central systolic BP whereby C2 calibration is clearly superior to cuff brachial SBP and C1 calibration in terms of association with hypertension‐associated organ damage 22 , 23 , 24 , 25 and mortality outcomes. 26 Also, in small studies the estimated aortic PWV shows some prognostic value. 27 , 28 Investigations on the potential input of more sophisticated steady‐state or pulsatile hemodynamics are lacking so far. The study of Ntineri and colleagues provides interesting new data on non‐invasive 24‐hour ambulatory hemodynamics in children and adolescents. To stimulate further research in this field, the authors of this commentary invite colleagues around the world to join the academic international 24‐hour aortic blood pressure consortium (www.i24abc.org). More than 30 centers from 6 continents currently contribute to the consortium.

DISCLOSURES

SW is one of the inventors (not holder) of a patent partly used in the ARCSolver Algorithms, which are used for waveform analysis in the Mobil‐O‐Graph 24h PWA device.

Weber T, Protogerou AD, Sharman JE, Wassertheurer S. Pulsatile and steady‐state 24‐hour hemodynamics in adolescents and young adults: The next steps ahead. J Clin Hypertens. 2020;22:1797–1799. 10.1111/jch.13969

REFERENCES

  • 1. Anonymous . Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1028‐1034. [PubMed] [Google Scholar]
  • 2. Nardin C, Maki‐Petaja KM, Miles KL, et al. Cardiovascular phenotype of elevated blood pressure differs markedly between young males and females: the enigma study. Hypertension. 2018;72:1277‐1284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. SHEP Cooperative Research Group . Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255‐3264. [PubMed] [Google Scholar]
  • 4. Weber T, Wassertheurer S, Rammer M, et al. Validation of a brachial cuff‐based method for estimating central systolic blood pressure. Hypertension. 2011;58:825‐832. [DOI] [PubMed] [Google Scholar]
  • 5. Rajzer MW, Wojciechowska W, Klocek M, Palka I, Brzozowska‐Kiszka M, Kawecka‐Jaszcz K. Comparison of aortic pulse wave velocity measured by three techniques: complior, SphygmoCor and Arteriograph. J Hypertens. 2008;26:2001‐2007. [DOI] [PubMed] [Google Scholar]
  • 6. Omboni S, Posokhov I, Parati G, et al. Ambulatory blood pressure and arterial stiffness web‐based telemonitoring in patients at cardiovascular risk. First results of the VASOTENS (Vascular health ASsessment Of The hypertENSive patients) Registry. J Clin Hypertens (Greenwich). 2019;21:1155‐1168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Ntineria AKA, Zeniodia MA, Vazeou A, Soldatou A, Stergiou GS. Insight into the 24‐hour ambulatory central blood pressure in adolescents and young adults. J Clin Hypertens. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Mayer CCCR, Hametner B, Bruno RM. The European COST action VascAgeNet fostering innovation – when industry comes to science. Artery Res. 2020. 10.2991/artres.k.200430.001 [DOI] [Google Scholar]
  • 9. Weiss W, Tolle M, Zidek W, van der Giet M. Validation of the mobil‐O‐Graph: 24 h‐blood pressure measurement device. Blood Pres Monit. 2010;15:225‐228. [DOI] [PubMed] [Google Scholar]
  • 10. Franssen PM, Imholz BP. Evaluation of the Mobil‐O‐Graph new generation ABPM device using the ESH criteria. Blood Pres Monit. 2010;15:229‐231. [DOI] [PubMed] [Google Scholar]
  • 11. Gotzmann M, Hogeweg M, Seibert FS, et al. Accuracy of fully automated oscillometric central aortic blood pressure measurement techniques. J Hypertens. 2020;38:235‐242. [DOI] [PubMed] [Google Scholar]
  • 12. Wassertheurer S, Kropf J, Weber T, et al. A new oscillometric method for pulse wave analysis: comparison with a common tonometric method. J Hum Hypertens. 2010;24:498‐504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Benas D, Kornelakis M, Triantafyllidi H, et al. Pulse wave analysis using the Mobil‐O‐Graph, Arteriograph and Complior device: a comparative study. Blood Press. 2019;28:107‐113. [DOI] [PubMed] [Google Scholar]
  • 14. Weber T, Wassertheurer S, Hametner B, Parragh S, Eber B. Noninvasive methods to assess pulse wave velocity: comparison with the invasive gold standard and relationship with organ damage. J Hypertens. 2015;33:1023‐1031. [DOI] [PubMed] [Google Scholar]
  • 15. Feistritzer HJ, Reinstadler SJ, Klug G, et al. Comparison of an oscillometric method with cardiac magnetic resonance for the analysis of aortic pulse wave velocity. PLoS One. 2015;10:e0116862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Weber TWS, Middlemiss J, McEniery CM, et al. Validation of a method to estimate stroke volume from brachial‐cuff derived pressure waveforms. Artery Res. 2020;26:42‐47. [Google Scholar]
  • 17. Papaioannou TG, Xanthis D, Argyris A, et al. Accuracy and precision of cardiac output estimation by an automated, brachial cuff‐based oscillometric device in patients with shock. Proc Inst Mech Eng H. 2019. 10.1177/0954411919888321. [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
  • 18. Shiraishi M, Murakami T, Higashi K. The accuracy of central blood pressure obtained by oscillometric noninvasive method using Mobil‐O‐Graph in children and adolescents. J Hypertens. 2020;38:813‐820. [DOI] [PubMed] [Google Scholar]
  • 19. Mynard JP, Goldsmith G, Springall G, et al. Central aortic blood pressure estimation in children and adolescents: results of the KidCoreBP study. J Hypertens. 2020;38:821‐828. [DOI] [PubMed] [Google Scholar]
  • 20. Papaioannou TG, Karageorgopoulou TD, Sergentanis TN, et al. Accuracy of commercial devices and methods for noninvasive estimation of aortic systolic blood pressure a systematic review and meta‐analysis of invasive validation studies. J Hypertens. 2016;34:1237‐1248. [DOI] [PubMed] [Google Scholar]
  • 21. Picone DS, Schultz MG, Otahal P, et al. Influence of age on upper arm cuff blood pressure measurement. Hypertension. 2020;75:844‐850. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Protogerou AD, Argyris AA, Papaioannou TG, et al. Left‐ventricular hypertrophy is associated better with 24‐h aortic pressure than 24‐h brachial pressure in hypertensive patients: the SAFAR study. J Hypertens. 2014;32:1805‐1814. [DOI] [PubMed] [Google Scholar]
  • 23. Weber T, Wassertheurer S, Schmidt‐Trucksass A, et al. Relationship between 24‐hour ambulatory central systolic blood pressure and left ventricular mass: a prospective multicenter study. Hypertension. 2017;70:1157‐1164. [DOI] [PubMed] [Google Scholar]
  • 24. Negishi K, Yang H, Wang Y, et al. importance of calibration method in central blood pressure for cardiac structural abnormalities. Am J Hypertens. 2016;29:1070‐1076. [DOI] [PubMed] [Google Scholar]
  • 25. Zhang Y, Kollias G, Argyris AA, et al. Association of left ventricular diastolic dysfunction with 24‐h aortic ambulatory blood pressure: the SAFAR study. J Hum Hypertens. 2015;29:442‐448. [DOI] [PubMed] [Google Scholar]
  • 26. Wassertheurer S, Baumann M. Assessment of systolic aortic pressure and its association to all cause mortality critically depends on waveform calibration. J Hypertens. 2015;33:1884‐1888. discussion 1889. [DOI] [PubMed] [Google Scholar]
  • 27. Matschkal J, Mayer CC, Sarafidis PA, et al. Comparison of 24‐hour and office pulse wave velocity for prediction of mortality in hemodialysis patients. Am J Nephrol. 2019;49:317‐327. [DOI] [PubMed] [Google Scholar]
  • 28. Baumann M, Wassertheurer S, Suttmann Y, Burkhardt K, Heemann U. Aortic pulse wave velocity predicts mortality in chronic kidney disease stages 2–4. J Hypertens. 2014;32:899‐903. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Clinical Hypertension are provided here courtesy of Wiley

RESOURCES